The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens
Open accessAbstract
The ESKAPE pathogens (Enterococcus faecium,Staphylococcus aureus,Klebsiella pneumoniae,Acinetobacter baumannii,Pseudomonas aeruginosa, and Enterobacter species) are the leading cause of nosocomial infections throughout the world. Most of them are multidrug resistant isolates, which is one of the greatest challenges in clinical practice. Multidrug resistance is amongst the top three threats to global public health and is usually caused by excessive drug usage or prescription, inappropriate use of antimicrobials, and substandard pharmaceuticals. Understanding the resistance mechanisms of these bacteria is crucial for the development of novel antimicrobial agents or other alternative tools to combat these public health challenges. Greater mechanistic understanding would also aid in the prediction of underlying or even unknown mechanisms of resistance, which could be applied to other emerging multidrug resistant pathogens. In this review, we summarize the known antimicrobial resistance mechanisms of ESKAPE pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002
Klevens, R. M., Edwards, J. R., Richards, C. L., Horan, T. C., Gaynes, R. P., Pollock, D. A., & Cardo, D. M. (2007) · Public Health Reports® · doi:10.1177/003335490712200205 · Cited by 2,960
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367 · cited 2×
“These bacteria are common causes of life-threatening nosocomial infections amongst critically ill and immunocompromised individuals and are characterized by potential drug resistance mechanisms [5].”
BackgroundFederal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
The rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
VANCOMYCIN-RESISTANT ENTEROCOCCI
Uttley, A. C., Collins, C. H., Naidoo, J., & George, R. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91037-9 · Cited by 1,226
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Jacoby, G. A., & Munoz-Price, L. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041359 · Cited by 787
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria
Nikaido, H., & Pagès, J.-M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00290.x · Cited by 769
Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations
Sun, J., Deng, Z., & Yan, A. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.090 · Cited by 746
The Challenge of Treating Biofilm-associated Bacterial Infections
del Pozo, J. L., & Patel, R. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100247 · Cited by 671
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii
Vila, J., Martí, S., & Sánchez-Céspedes, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl509 · Cited by 436
Progress and Challenges in Implementing the Research on ESKAPE Pathogens
Rice, L. B. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/655995 · Cited by 370
Antibiotic Resistance Mechanisms in Bacteria: Biochemical and Genetic Aspects
Kos, B., Džidić, S., & Šušković, J. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 362
Castanheira, M., Deshpande, L. M., Mathai, D., Bell, J. M., Jones, R. N., & Mendes, R. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-10 · Cited by 362
Antibiotic Resistance Mechanisms of Clinically Important Bacteria
Giedraitienė, A., Vitkauskienė, A., Naginienė, R., & Pavilonis, A. (2011) · Medicina · doi:10.3390/medicina47030019 · Cited by 362
Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria
Zhao, W.-H., & Hu, Z.-Q. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.691460 · Cited by 302
Schweizer, H. P. (2003) · PubMed · Cited by 287
Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)
Appelbaum, P. C. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.07.011 · Cited by 248
What's new in antibiotic resistance? Focus on beta-lactamases
BABIC, M., HUJER, A., & BONOMO, R. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.05.005 · Cited by 239
Pseudomonas aeruginosa biofilm: Potential therapeutic targets
Sharma, G., Rao, S., Bansal, A., Dang, S., Gupta, S., & Gabrani, R. (2014) · Biologicals · doi:10.1016/j.biologicals.2013.11.001 · Cited by 222
Philippon, L. N., Naas, T., Bouthors, A. T., Barakett, V, & Nordmann, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2188 · Cited by 215
The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril!
Thomson, J. M., & Bonomo, R. A. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.014 · Cited by 212
Tang, S. S., Apisarnthanarak, A., & Hsu, L. Y. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.08.003 · Cited by 182
Biomolecular Mechanisms of Pseudomonas aeruginosa and Escherichia coli Biofilm Formation
Laverty, G., Gorman, S., & Gilmore, B. (2014) · Pathogens · doi:10.3390/pathogens3030596 · Cited by 179
Microbiology of Antibiotic Resistance in Staphylococcus aureus
Appelbaum, P. C. (2007) · Clinical Infectious Diseases · doi:10.1086/519474 · Cited by 176
Virulence Factors of Enterococcus faecalis and Enterococcus faecium Blood Culture Isolates
Elsner, H.-A., Sobottka, I., Mack, D., Laufs, R., Claussen, M., & Wirth, R. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050007 · Cited by 168
Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06
Hope, R., Livermore, D. M., Brick, G., Lillie, M., Reynolds, R., & Surveillance, O. B. O. T. B. W. P. O. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn353 · Cited by 117
Wu, D., Wang, Q., Yang, Y., Geng, W., Wang, Q., Yu, S., Yao, K., Yuan, L., & Shen, X. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.12.006 · Cited by 113
Emergence of Clonal Complex 17 Enterococcus faecium in The Netherlands
Top, J., Willems, R. J. L., van der Velden, S., van Luit‐Asbroek, M., & Bonten, M. J. M. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01351-07 · Cited by 106
Vancomycin-resistant enterococci
Uttley, A. H. C., Woodford, N., Johnson, A. P., Cookson, B., George, R. C., Wilcox, M., Spencer, R. C., Weeks, G., Frieden, T. R., Munsiff, S. S., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91440-w · Cited by 85
Indrawattana, N., Sungkhachat, O., Sookrung, N., Chongsa-nguan, M., Tungtrongchitr, A., Voravuthikunchai, S. P., Kong-Ngoen, T., Kurazono, H., & Chaicumpa, W. (2013) · BioMed Research International · doi:10.1155/2013/314654 · Cited by 55
Self-citationFukuoka, T., Ohya, S., Narita, T., Katsuta, M., Iijima, M., Masuda, N., Yasuda, H., Trias, J., & Nikaido, H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.322 · Cited by 51
Brown, P. D., & Ngeno, C. (2006) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.04.005 · Cited by 46
Pucci, M. J., & Dougherty, T. J. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.2.588-591.2002 · Cited by 38
Safaei, H. G., Vaez, H., Faghri, J., Isfahani, B., Moghim, S., Yadegari, S., Fazeli, H., & Moghofeei, M. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.133183 · Cited by 27
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Health care-associated infections – an overview
Haque, M., Sartelli, M., McKimm, J., & Abu Bakar, M. B. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s177247 · Cited by 1,200
Makvandi, P., Wang, C., Zare, E. N., Borzacchiello, A., Niu, L., & Tay, F. R. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910021 · Cited by 737
Metadata
- Authors
- Santajit, S., & Indrawattana, N.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-8
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2347102183
- Cited by
- 1,641
- References
- 48
- FWCI
- 31.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.